Security record · archived quarter
TECH
Bio-Techne Corporation · Healthcare · Biotechnology
10Tracked holders
—Δ holders
19.47MShares held
$1.39BReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 147 | +11 | 118.94M | $8.37B | +19 | −7 |
| Q1 2026 | 138 | +4 | 119.63M | $6.27B | +11 | −8 |
| Q4 2025 | 133 | -3 | 119.40M | $7.02B | +1 | −3 |
| Q3 2025 | 21 | +2 | 61.92M | $3.44B | +4 | −3 |
| Q2 2025 | 17 | 0 | 59.03M | $3.04B | +2 | −2 |
| Q1 2025 | 14 | +2 | 27.35M | $1.60B | +3 | −1 |
| Q4 2024 | 12 | 0 | 29.06M | $2.09B | +1 | −1 |
| Q3 2024 | 11 | +1 | 22.54M | $1.80B | +2 | −1 |
| Q2 2024 | 10 | — | 19.47M | $1.39B | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 8.53M | — | $610.87M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 8.53M | — | $610.87M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 3.91M | — | $279.19M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 3.91M | — | $279.19M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Marshall Wace ✦ | 1.98M | — | $142.13M | 0.2% | n/c | 1 | SEC ↗ |
| 6 | Norges Bank ✦ (passive) | 1.90M | — | $136.43M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.68M | — | $120.40M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.68M | — | $120.40M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.68M | — | $120.40M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.68M | — | $120.40M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Millennium Management ✦ | 1.12M | — | $80.57M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 257.94K | — | $18.48M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 257.94K | — | $18.48M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 50.23K | — | $3.60M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 50.23K | — | $3.60M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 35.50K | — | $2.54M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 3.35K | — | $239,956 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 426.80K shares, $22,304 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Aug 06
SC 13G/A — FMR LLC
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API